ROSWELL PARK ALLIANCE FOUNDATION
Programs
Cancer Research Support Programs
The Foundation supports robust cancer research programs by disease site and key areas such as Cell Stress and Biophysical Therapies, Developmental Therapeutics, Genetics and Genomics, Population Sciences, and Tumor Immunology and Immunotherapy as these research programs relate to finding cures for all types of cancer. Donations made to the Foundation are administered to targeted cancer research programs as indicated. Grants are awarded through our Scientific Advisory Committee, a competitive peer-reviewed process where 25 physicians and scientists select the most promising studies showing the greatest potential to obtain extramural peer-reviewed research funding with the goal to find cures and save lives.GeographiesNot indicatedDatesApr 1, 2021 – Mar 31, 2022Source990No causes providedNo populations provided–$9.2MImmunotherapy Access and Research
Roswell Park's Center for Immunotherapy is dedicated to speeding access to the most promising immunotherapy treatments through clinical trials. The Release the Breakthroughs Campaign was launched to enable these trials to move faster and more efficiently to bring advancements to cancer patients. The Campaign is also supporting translational research and innovation, precision medicine and advances in genetic and biomarker research, enabling capital projects and patient education and support.GeographiesNot indicatedDatesApr 1, 2021 – Mar 31, 2022Source990No causes providedNo populations provided–$5.6MQuality of Life Grants for Cancer Patients
"Quality of life" grants are awarded each year to programs focused on improving the patient and family experience during cancer treatment. Examples of such programs include the Courage of Carly Fund (programs for pediatric cancer patients and families), the Resource Center, Pastoral Care, and Psychosocial Oncology. Such programs help Roswell patients at their critical time of need and ensure that patients' families' questions and concerns outside the clinic setting are met with one-on-one guidance, no matter the hour, during their cancer journey.GeographiesNot indicatedDatesApr 1, 2021 – Mar 31, 2022Source990No causes providedNo populations provided–$3.1M
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)